Article
Author(s):
A look back at some of the top stories on Specialty Pharmacy Times from March 16-20.
A look back at some of the top stories on Specialty Pharmacy Times from March 16-20.
Nanoparticles May Increase Effectiveness of Lung Cancer Drugs
Treatment can selectively drop medication at the site of tumors.
New Approach Needed to Finance Expensive Specialty Drugs
Report finds suppliers could spur investment through methods that include equipment leases or supplier-financed credit.
http://www.specialtypharmacytimes.com/news/New-Approach-Needed-to-Finance-Expensive-Specialty-Drugs
FDA Accepts Combination Hepatitis C Treatment Application for Review
Bristol-Myers Squibb is also clinically testing the potential of daclatasvir-based regimens in patients co-infected with HIV.
Preventing Early Menopause in Breast Cancer Patients
Risk of sudden onset menopause reduced by adding goserelin to chemotherapy regimen.
http://www.specialtypharmacytimes.com/news/Preventing-Early-Menopause-in-Breast-Cancer-Patients
FDA Approves Treatment for Bile Acid Synthesis Disorders
First treatment option approved for rare condition.
http://www.specialtypharmacytimes.com/news/FDA-Approves-Treatment-for-Bile-Acid-Synthesis-Disorders
Improper Temperature Control: A Global Problem
Globally, from Tunisia to the United States, underuse of digital temperature loggers leads to loss of product potency and efficacy for patients.
http://www.specialtypharmacytimes.com/news/Improper-Temperature-Control-A-Global-Problem
Gene Therapy Could Generate Powerful Hemophilia Treatment
Process produces protein with high blood clotting ability.
http://www.specialtypharmacytimes.com/news/Gene-Therapy-Could-Generate-Powerful-Hemophilia-Treatment
Herpes Drug May Lower HIV Levels
Study finds HIV-1 viral loads decreased following treatment with Valtrex.
http://www.specialtypharmacytimes.com/news/Herpes-Drug-May-Lower-HIV-Levels
Antibody Therapy Shows Promise in Halting Psoriasis
Experimental treatment blocks signaling protein.
http://www.specialtypharmacytimes.com/news/Antibody-Therapy-Shows-Promise-in-Halting-Psoriasis
Antisense Technology Shows Promising Results in Crohn’s Disease Treatment
Significant number of patients taking once daily oral therapy achieve clinical remission during a recent trial.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa